Global Pneumococcal 13 Valent Conjugate Vaccine Market Research Report 2026(Status and Outlook)
The Pneumococcal 13-valent Conjugate Vaccine (PCV13) is a vaccine designed to protect against infections caused by Streptococcus pneumoniae bacteria, commonly known as pneumococcus. It targets 13 specific strains (or serotypes) of the bacteria, which are responsible for severe illnesses such as pneumonia, meningitis, and sepsis. By preventing these infections, PCV13 is particularly important in protecting young children, and people with weakened immune systems.
The global Pneumococcal 13 Valent Conjugate Vaccine market size was estimated at USD 7250.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pneumococcal 13 Valent Conjugate Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pneumococcal 13 Valent Conjugate Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pneumococcal 13 Valent Conjugate Vaccine market.
Global Pneumococcal 13 Valent Conjugate Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Walvax
BIOKANGTAI
Market Segmentation (by Type)
0.5ml
Other
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal 13 Valent Conjugate Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pneumococcal 13 Valent Conjugate Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Pneumococcal 13 Valent Conjugate Vaccine market size was estimated at USD 7250.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pneumococcal 13 Valent Conjugate Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pneumococcal 13 Valent Conjugate Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pneumococcal 13 Valent Conjugate Vaccine market.
Global Pneumococcal 13 Valent Conjugate Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Walvax
BIOKANGTAI
Market Segmentation (by Type)
0.5ml
Other
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pneumococcal 13 Valent Conjugate Vaccine Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal 13 Valent Conjugate Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pneumococcal 13 Valent Conjugate Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pneumococcal 13 Valent Conjugate Vaccine
1.2 Key Market Segments
1.2.1 Pneumococcal 13 Valent Conjugate Vaccine Segment by Type
1.2.2 Pneumococcal 13 Valent Conjugate Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pneumococcal 13 Valent Conjugate Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pneumococcal 13 Valent Conjugate Vaccine Product Life Cycle
3.3 Global Pneumococcal 13 Valent Conjugate Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Pneumococcal 13 Valent Conjugate Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Pneumococcal 13 Valent Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pneumococcal 13 Valent Conjugate Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pneumococcal 13 Valent Conjugate Vaccine Market Competitive Situation and Trends
3.8.1 Pneumococcal 13 Valent Conjugate Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pneumococcal 13 Valent Conjugate Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Pneumococcal 13 Valent Conjugate Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pneumococcal 13 Valent Conjugate Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pneumococcal 13 Valent Conjugate Vaccine Market
5.7 ESG Ratings of Leading Companies
6 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Type (2020-2025)
6.4 Global Pneumococcal 13 Valent Conjugate Vaccine Price by Type (2020-2025)
7 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Sales by Application (2020-2025)
7.3 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Pneumococcal 13 Valent Conjugate Vaccine Sales Growth Rate by Application (2020-2025)
8 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET SALES BY REGION
8.1 Global Pneumococcal 13 Valent Conjugate Vaccine Sales by Region
8.1.1 Global Pneumococcal 13 Valent Conjugate Vaccine Sales by Region
8.1.2 Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Region
8.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region
8.2.1 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region
8.2.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region
8.3 North America
8.3.1 North America Pneumococcal 13 Valent Conjugate Vaccine Sales by Country
8.3.2 North America Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pneumococcal 13 Valent Conjugate Vaccine Sales by Country
8.4.2 Europe Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Sales by Region
8.5.2 Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pneumococcal 13 Valent Conjugate Vaccine Sales by Country
8.6.2 South America Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Sales by Region
8.7.2 Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Pneumococcal 13 Valent Conjugate Vaccine by Region(2020-2025)
9.2 Global Pneumococcal 13 Valent Conjugate Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Pneumococcal 13 Valent Conjugate Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pneumococcal 13 Valent Conjugate Vaccine Production
9.4.1 North America Pneumococcal 13 Valent Conjugate Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Pneumococcal 13 Valent Conjugate Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pneumococcal 13 Valent Conjugate Vaccine Production
9.5.1 Europe Pneumococcal 13 Valent Conjugate Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Pneumococcal 13 Valent Conjugate Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pneumococcal 13 Valent Conjugate Vaccine Production (2020-2025)
9.6.1 Japan Pneumococcal 13 Valent Conjugate Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Pneumococcal 13 Valent Conjugate Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pneumococcal 13 Valent Conjugate Vaccine Production (2020-2025)
9.7.1 China Pneumococcal 13 Valent Conjugate Vaccine Production Growth Rate (2020-2025)
9.7.2 China Pneumococcal 13 Valent Conjugate Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Pneumococcal 13 Valent Conjugate Vaccine Product Overview
10.1.3 Pfizer Pneumococcal 13 Valent Conjugate Vaccine Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Walvax
10.2.1 Walvax Basic Information
10.2.2 Walvax Pneumococcal 13 Valent Conjugate Vaccine Product Overview
10.2.3 Walvax Pneumococcal 13 Valent Conjugate Vaccine Product Market Performance
10.2.4 Walvax Business Overview
10.2.5 Walvax SWOT Analysis
10.2.6 Walvax Recent Developments
10.3 BIOKANGTAI
10.3.1 BIOKANGTAI Basic Information
10.3.2 BIOKANGTAI Pneumococcal 13 Valent Conjugate Vaccine Product Overview
10.3.3 BIOKANGTAI Pneumococcal 13 Valent Conjugate Vaccine Product Market Performance
10.3.4 BIOKANGTAI Business Overview
10.3.5 BIOKANGTAI SWOT Analysis
10.3.6 BIOKANGTAI Recent Developments
11 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET FORECAST BY REGION
11.1 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast
11.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Region
11.2.4 South America Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pneumococcal 13 Valent Conjugate Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pneumococcal 13 Valent Conjugate Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pneumococcal 13 Valent Conjugate Vaccine by Type (2026-2035)
12.1.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pneumococcal 13 Valent Conjugate Vaccine by Type (2026-2035)
12.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pneumococcal 13 Valent Conjugate Vaccine
1.2 Key Market Segments
1.2.1 Pneumococcal 13 Valent Conjugate Vaccine Segment by Type
1.2.2 Pneumococcal 13 Valent Conjugate Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pneumococcal 13 Valent Conjugate Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pneumococcal 13 Valent Conjugate Vaccine Product Life Cycle
3.3 Global Pneumococcal 13 Valent Conjugate Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Pneumococcal 13 Valent Conjugate Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Pneumococcal 13 Valent Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pneumococcal 13 Valent Conjugate Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pneumococcal 13 Valent Conjugate Vaccine Market Competitive Situation and Trends
3.8.1 Pneumococcal 13 Valent Conjugate Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pneumococcal 13 Valent Conjugate Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Pneumococcal 13 Valent Conjugate Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pneumococcal 13 Valent Conjugate Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pneumococcal 13 Valent Conjugate Vaccine Market
5.7 ESG Ratings of Leading Companies
6 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Type (2020-2025)
6.4 Global Pneumococcal 13 Valent Conjugate Vaccine Price by Type (2020-2025)
7 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Sales by Application (2020-2025)
7.3 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Pneumococcal 13 Valent Conjugate Vaccine Sales Growth Rate by Application (2020-2025)
8 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET SALES BY REGION
8.1 Global Pneumococcal 13 Valent Conjugate Vaccine Sales by Region
8.1.1 Global Pneumococcal 13 Valent Conjugate Vaccine Sales by Region
8.1.2 Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Region
8.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region
8.2.1 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region
8.2.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region
8.3 North America
8.3.1 North America Pneumococcal 13 Valent Conjugate Vaccine Sales by Country
8.3.2 North America Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pneumococcal 13 Valent Conjugate Vaccine Sales by Country
8.4.2 Europe Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Sales by Region
8.5.2 Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pneumococcal 13 Valent Conjugate Vaccine Sales by Country
8.6.2 South America Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Sales by Region
8.7.2 Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Pneumococcal 13 Valent Conjugate Vaccine by Region(2020-2025)
9.2 Global Pneumococcal 13 Valent Conjugate Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Pneumococcal 13 Valent Conjugate Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pneumococcal 13 Valent Conjugate Vaccine Production
9.4.1 North America Pneumococcal 13 Valent Conjugate Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Pneumococcal 13 Valent Conjugate Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pneumococcal 13 Valent Conjugate Vaccine Production
9.5.1 Europe Pneumococcal 13 Valent Conjugate Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Pneumococcal 13 Valent Conjugate Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pneumococcal 13 Valent Conjugate Vaccine Production (2020-2025)
9.6.1 Japan Pneumococcal 13 Valent Conjugate Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Pneumococcal 13 Valent Conjugate Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pneumococcal 13 Valent Conjugate Vaccine Production (2020-2025)
9.7.1 China Pneumococcal 13 Valent Conjugate Vaccine Production Growth Rate (2020-2025)
9.7.2 China Pneumococcal 13 Valent Conjugate Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Pneumococcal 13 Valent Conjugate Vaccine Product Overview
10.1.3 Pfizer Pneumococcal 13 Valent Conjugate Vaccine Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Walvax
10.2.1 Walvax Basic Information
10.2.2 Walvax Pneumococcal 13 Valent Conjugate Vaccine Product Overview
10.2.3 Walvax Pneumococcal 13 Valent Conjugate Vaccine Product Market Performance
10.2.4 Walvax Business Overview
10.2.5 Walvax SWOT Analysis
10.2.6 Walvax Recent Developments
10.3 BIOKANGTAI
10.3.1 BIOKANGTAI Basic Information
10.3.2 BIOKANGTAI Pneumococcal 13 Valent Conjugate Vaccine Product Overview
10.3.3 BIOKANGTAI Pneumococcal 13 Valent Conjugate Vaccine Product Market Performance
10.3.4 BIOKANGTAI Business Overview
10.3.5 BIOKANGTAI SWOT Analysis
10.3.6 BIOKANGTAI Recent Developments
11 PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE MARKET FORECAST BY REGION
11.1 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast
11.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Region
11.2.4 South America Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pneumococcal 13 Valent Conjugate Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pneumococcal 13 Valent Conjugate Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pneumococcal 13 Valent Conjugate Vaccine by Type (2026-2035)
12.1.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pneumococcal 13 Valent Conjugate Vaccine by Type (2026-2035)
12.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Type (M USD)
Table 4. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Application
Table 5. Pneumococcal 13 Valent Conjugate Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pneumococcal 13 Valent Conjugate Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pneumococcal 13 Valent Conjugate Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal 13 Valent Conjugate Vaccine as of 2025)
Table 11. Global Market Pneumococcal 13 Valent Conjugate Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Pneumococcal 13 Valent Conjugate Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pneumococcal 13 Valent Conjugate Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pneumococcal 13 Valent Conjugate Vaccine Sales by Type (K MT)
Table 27. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Type (M USD)
Table 28. Global Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share by Type (2020-2025)
Table 32. Global Pneumococcal 13 Valent Conjugate Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) by Application
Table 34. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Application
Table 35. Global Pneumococcal 13 Valent Conjugate Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share by Application (2020-2025)
Table 39. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Pneumococcal 13 Valent Conjugate Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region (2020-2025)
Table 44. North America Pneumococcal 13 Valent Conjugate Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pneumococcal 13 Valent Conjugate Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pneumococcal 13 Valent Conjugate Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pneumococcal 13 Valent Conjugate Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Pneumococcal 13 Valent Conjugate Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pneumococcal 13 Valent Conjugate Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Pneumococcal 13 Valent Conjugate Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Pneumococcal 13 Valent Conjugate Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Pneumococcal 13 Valent Conjugate Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Pneumococcal 13 Valent Conjugate Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Pneumococcal 13 Valent Conjugate Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Pneumococcal 13 Valent Conjugate Vaccine Product Overview
Table 64. Pfizer Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Walvax Basic Information
Table 69. Walvax Pneumococcal 13 Valent Conjugate Vaccine Product Overview
Table 70. Walvax Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Walvax Business Overview
Table 72. Walvax SWOT Analysis
Table 73. Walvax Recent Developments
Table 74. BIOKANGTAI Basic Information
Table 75. BIOKANGTAI Pneumococcal 13 Valent Conjugate Vaccine Product Overview
Table 76. BIOKANGTAI Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. BIOKANGTAI Business Overview
Table 78. BIOKANGTAI SWOT Analysis
Table 79. BIOKANGTAI Recent Developments
Table 80. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 81. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 82. North America Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 83. North America Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 84. Europe Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 85. Europe Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 86. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 87. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 88. South America Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 89. South America Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 90. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 91. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 92. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 93. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 94. Global Pneumococcal 13 Valent Conjugate Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 95. Global Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 96. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Type (M USD)
Table 4. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Application
Table 5. Pneumococcal 13 Valent Conjugate Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pneumococcal 13 Valent Conjugate Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pneumococcal 13 Valent Conjugate Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal 13 Valent Conjugate Vaccine as of 2025)
Table 11. Global Market Pneumococcal 13 Valent Conjugate Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Pneumococcal 13 Valent Conjugate Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pneumococcal 13 Valent Conjugate Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pneumococcal 13 Valent Conjugate Vaccine Sales by Type (K MT)
Table 27. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Type (M USD)
Table 28. Global Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share by Type (2020-2025)
Table 32. Global Pneumococcal 13 Valent Conjugate Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) by Application
Table 34. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Application
Table 35. Global Pneumococcal 13 Valent Conjugate Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share by Application (2020-2025)
Table 39. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Pneumococcal 13 Valent Conjugate Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region (2020-2025)
Table 44. North America Pneumococcal 13 Valent Conjugate Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pneumococcal 13 Valent Conjugate Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pneumococcal 13 Valent Conjugate Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pneumococcal 13 Valent Conjugate Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Pneumococcal 13 Valent Conjugate Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pneumococcal 13 Valent Conjugate Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Pneumococcal 13 Valent Conjugate Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Pneumococcal 13 Valent Conjugate Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Pneumococcal 13 Valent Conjugate Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Pneumococcal 13 Valent Conjugate Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Pneumococcal 13 Valent Conjugate Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Pneumococcal 13 Valent Conjugate Vaccine Product Overview
Table 64. Pfizer Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Walvax Basic Information
Table 69. Walvax Pneumococcal 13 Valent Conjugate Vaccine Product Overview
Table 70. Walvax Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Walvax Business Overview
Table 72. Walvax SWOT Analysis
Table 73. Walvax Recent Developments
Table 74. BIOKANGTAI Basic Information
Table 75. BIOKANGTAI Pneumococcal 13 Valent Conjugate Vaccine Product Overview
Table 76. BIOKANGTAI Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. BIOKANGTAI Business Overview
Table 78. BIOKANGTAI SWOT Analysis
Table 79. BIOKANGTAI Recent Developments
Table 80. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 81. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 82. North America Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 83. North America Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 84. Europe Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 85. Europe Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 86. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 87. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 88. South America Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 89. South America Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 90. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 91. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 92. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 93. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 94. Global Pneumococcal 13 Valent Conjugate Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 95. Global Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 96. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pneumococcal 13 Valent Conjugate Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pneumococcal 13 Valent Conjugate Vaccine Product Life Cycle
Figure 13. Pneumococcal 13 Valent Conjugate Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Pneumococcal 13 Valent Conjugate Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Pneumococcal 13 Valent Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pneumococcal 13 Valent Conjugate Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pneumococcal 13 Valent Conjugate Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Pneumococcal 13 Valent Conjugate Vaccine
Figure 19. Global Pneumococcal 13 Valent Conjugate Vaccine Market PEST Analysis
Figure 20. Global Pneumococcal 13 Valent Conjugate Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share by Type
Figure 27. Sales Market Share of Pneumococcal 13 Valent Conjugate Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Pneumococcal 13 Valent Conjugate Vaccine by Type in 2025
Figure 29. Market Share of Pneumococcal 13 Valent Conjugate Vaccine by Type (2020-2025)
Figure 30. Market Share of Pneumococcal 13 Valent Conjugate Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share by Application
Figure 33. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Application in 2025
Figure 35. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share by Application (2020-2025)
Figure 36. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share by Application in 2025
Figure 37. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region (2020-2025)
Figure 40. North America Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Country in 2024
Figure 43. North America Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country in 2024
Figure 45. U.S. Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pneumococcal 13 Valent Conjugate Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pneumococcal 13 Valent Conjugate Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country in 2024
Figure 55. Germany Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region in 2024
Figure 68. China Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Country in 2024
Figure 80. South America Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country in 2024
Figure 82. Brazil Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pneumococcal 13 Valent Conjugate Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Pneumococcal 13 Valent Conjugate Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pneumococcal 13 Valent Conjugate Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pneumococcal 13 Valent Conjugate Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pneumococcal 13 Valent Conjugate Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Pneumococcal 13 Valent Conjugate Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pneumococcal 13 Valent Conjugate Vaccine Product Life Cycle
Figure 13. Pneumococcal 13 Valent Conjugate Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Pneumococcal 13 Valent Conjugate Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Pneumococcal 13 Valent Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pneumococcal 13 Valent Conjugate Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pneumococcal 13 Valent Conjugate Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Pneumococcal 13 Valent Conjugate Vaccine
Figure 19. Global Pneumococcal 13 Valent Conjugate Vaccine Market PEST Analysis
Figure 20. Global Pneumococcal 13 Valent Conjugate Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share by Type
Figure 27. Sales Market Share of Pneumococcal 13 Valent Conjugate Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Pneumococcal 13 Valent Conjugate Vaccine by Type in 2025
Figure 29. Market Share of Pneumococcal 13 Valent Conjugate Vaccine by Type (2020-2025)
Figure 30. Market Share of Pneumococcal 13 Valent Conjugate Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share by Application
Figure 33. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Application in 2025
Figure 35. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share by Application (2020-2025)
Figure 36. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share by Application in 2025
Figure 37. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region (2020-2025)
Figure 40. North America Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Country in 2024
Figure 43. North America Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country in 2024
Figure 45. U.S. Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pneumococcal 13 Valent Conjugate Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pneumococcal 13 Valent Conjugate Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pneumococcal 13 Valent Conjugate Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pneumococcal 13 Valent Conjugate Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country in 2024
Figure 55. Germany Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region in 2024
Figure 68. China Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Country in 2024
Figure 80. South America Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Pneumococcal 13 Valent Conjugate Vaccine Market Size by Country in 2024
Figure 82. Brazil Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pneumococcal 13 Valent Conjugate Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pneumococcal 13 Valent Conjugate Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pneumococcal 13 Valent Conjugate Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pneumococcal 13 Valent Conjugate Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Pneumococcal 13 Valent Conjugate Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pneumococcal 13 Valent Conjugate Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pneumococcal 13 Valent Conjugate Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pneumococcal 13 Valent Conjugate Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Pneumococcal 13 Valent Conjugate Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Pneumococcal 13 Valent Conjugate Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Pneumococcal 13 Valent Conjugate Vaccine Market Share Forecast by Application (2026-2035)
